A detailed history of Buckingham Strategic Partners transactions in Quidel Ortho Corp stock. As of the latest transaction made, Buckingham Strategic Partners holds 7,455 shares of QDEL stock, worth $211,871. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,455
Previous 10,874 31.44%
Holding current value
$211,871
Previous $380,000 43.68%
% of portfolio
0.0%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 31, 2025

SELL
$24.46 - $37.42 $83,628 - $127,938
-3,419 Reduced 31.44%
7,455 $214,000
Q1 2025

May 15, 2025

BUY
$34.78 - $47.61 $378,197 - $517,711
10,874 New
10,874 $380,000

Others Institutions Holding QDEL

About QuidelOrtho Corp


  • Ticker QDEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 66,952,900
  • Market Cap $1.9B
  • Description
  • QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tes...
More about QDEL
Track This Portfolio

Track Buckingham Strategic Partners Portfolio

Follow Buckingham Strategic Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Buckingham Strategic Partners, based on Form 13F filings with the SEC.

News

Stay updated on Buckingham Strategic Partners with notifications on news.